Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) reported Q2 EPS of ($1.97), $0.06 better than the analyst estimate of ($2.03). Revenue for the quarter came in at $100 million versus the consensus estimate of $99.91 million.
For earnings history and earnings-related data on Moderna (MRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Pathfinder Bancorp (PBHC) Tops Q2 EPS by 42c
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
